Wrap Text
Form 8-K current report
ASP ISOTOPES INC.
(Incorporated in the State of Delaware,
United States of America)
(Delaware file number 6228898)
Ticker Symbol: NASDAQ: ASPI
ISIN: US00218A1051
LEI: 6488WHV94BZ496OZ3219
JSE Share Code: ISO
("ASPI" or "the Company")
FORM 8-K CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, ASPI stockholders are advised
that a Form 8-K has been filed with the U.S. Securities and Exchange Commission.
On November 7, 2025, Quantum Leap Energy LLC ("QLE"), a wholly-owned subsidiary of the Company,
issued an investor presentation that provides an overview of QLE's business. A copy of the investor
presentation is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by
reference.
Also on November 7, 2025, the Company announced that QLE has commenced an offering of QLE
convertible promissory notes (the "QLE Notes") in a private placement to accredited investors and to certain
non-U.S. persons in transactions outside of the United States in reliance on Regulation S under the
Securities Act of 1933 (the "QLE Notes Offering"). QLE has entered into a definitive convertible note
purchase agreement with certain investors for an initial closing of $64.3 million of QLE Notes that was led
by American Ventures LLC, with the Company also making a significant investment in the QLE Notes. QLE
may issue additional QLE Notes in subsequent closings to investors who are non-U.S. persons in
transactions outside of the United States in reliance on Regulation S promulgated under the Securities Act
of 1933, as amended (the "Securities Act"). A copy of the press release announcing the QLE Notes Offering
is attached to this Current Report on Form 8-K as Exhibit 99.2 and is incorporated herein by reference.
The information in this Item 7.01, including Exhibits 99.1 and 99.2, shall not be deemed to be "filed" for
purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or
otherwise subject to the liability of that section, and shall not be incorporated by reference into any
registration statement or other document filed under the Securities Act, or the Exchange Act, except as
shall be expressly set forth by specific reference in such filing.
Forward-Looking Statements
Statements contained herein or in Exhibits 99.1 and 99.2 to this Current Report on Form 8-K relating to
future plans, results, performance, expectations, achievements and the like are considered "forward-looking
statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-
looking statements include, but are not limited to, QLE's ability to consummate the QLE Notes Offering;
QLE's financial performance and its ability to generate sufficient revenue to achieve and sustain
profitability; QLE's ability to obtain required regulatory approvals, complete its research and development
activities and manufacture, market and sell the products that it may produce; QLE's ability to achieve
success with new technological developments, including the development and deployment of SMRs and
advanced nuclear reactors; the anticipated growth of QLE's target markets for HALEU, Lithium 6 and
Lithium 7, and its ability to penetrate these markets; QLE's future capital requirements and sources and
uses of cash; QLE's ability to obtain funding for its operations and future growth; the ability to recognize the
anticipated benefits of acquisitions; QLE's inability to compete effectively; risks associated with the current
economic environment; risks associated with QLE's international operations; geopolitical risk and changes
in applicable laws or regulations; and QLE's inability to hire or retain skilled employees and the loss of any
of its key personnel. These forward-looking statements involve known and unknown risks, uncertainties,
and other factors, many of which may be beyond the QLE's control, that may cause actual results to differ
materially from any future results, performance or achievements expressed or implied by any forward-
looking statements.
All forward-looking statements speak only as of the date hereof. The Company and QLE undertake no
obligation to revise or update any forward-looking statements except as may be required by applicable law.
A copy of the Form 8-K can also be found at: Inline Viewer: ASP Isotopes Inc. 8-K 2025-11-07
7 November 2025
Sponsor
Valeo Capital Proprietary Limited
Date: 07-11-2025 04:58:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Sharenet Sites 
